Vivimed Labs is currently trading at Rs. 15.90, up by 1.05 points or 7.07% from its previous closing of Rs. 14.85 on the BSE.
The scrip opened at Rs. 14.85 and has touched a high and low of Rs. 16.15 and Rs. 14.60 respectively. So far 77849 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 23.62 on 25-Aug-2020 and a 52 week low of Rs. 6.50 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 16.90 and Rs. 14.40 respectively. The current market cap of the company is Rs. 131.00 crore.
The promoters holding in the company stood at 32.79%, while Institutions and Non-Institutions held 3.22% and 63.99% respectively.
Vivimed Labs has received approval for 1 product from Uzbekistan Government for its PICS & Health Canada approved site, both facilities are situated at Hyderabad. The product is Paracetamol 125 mg/5mL + Chlorpheniramine Maleate 2.5 mg/5mL syrup under brand name FEBRIL Syrup 100ml.
Paracetamol is also known as acetaminophen, is a medication used to treat pain and fever. Chlorpheniramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1820.65 |
Dr. Reddys Lab | 1350.30 |
Cipla | 1482.65 |
Lupin | 2184.20 |
Zydus Lifesciences | 977.20 |
View more.. |